δ EF1 represses BMP-2-induced differentiation of C2C12 myoblasts into the osteoblast lineage

Shuang Yang,Li Zhao,Juhua Yang,Dinggeng Chai,Ming Zhang,Jie Zhang,Xiaohui Ji,Tianhui Zhu
DOI: https://doi.org/10.1007/s11373-007-9155-5
2007-01-01
Journal of Biomedical Science
Abstract:Osteoblasts, derived from pluripotent mesenchymal precursor cells, acquire their differentiated phenotypes under the control of a series of regulatory factors, the best known of which is BMP-2. Our recent preliminary studies suggest that expression of δ EF1, a member of the zinc finger-homeodomain transcription factor family, is significantly down-regulated as human mesenchymal stem cells (MSCs) are subjected to osteoblastic differentiation in the presence of BMP-2. Here we demonstrate that overexpression of δ EF1 in murine pre-myoblast C2C12 cells resulted in a decrease in the mRNA levels of early osteoblast marker genes induced by BMP-2 including osterix and collagen type I. This inhibitory effect was further confirmed by decreased alkaline phosphatase (ALP) activities. Neither of the zinc finger clusters of δ EF1 is necessary for its repressive effect on BMP-2-induced osteoblastic differentiation of C2C12 cells. Immunoprecipitation results indicated that δ EF1 did not physically associate with Smads proteins, suggesting that the inhibitory effect of δ EF1 may be Smad-independent. δ EF1 overexpression in C2C12 cells resulted in down-regulation of activating protein-1 (AP-1) activities promoted by BMP-2. Moreover, δ EF1 exhibited transrepression on murine osteocalcin gene which effect is partially mediated through diminishing of AP-1 signaling. These results suggest that δ EF1 acts as a potent inhibitor of BMP-2-induced osteogenesis in vitro , in part, by differentially regulating the AP-1 signaling pathway.
What problem does this paper attempt to address?